Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Inspire Medical Systems, Inc. (INSP) Cash Flow Statement

Inspire Medical Systems, Inc. (INSP) generated $157.1M of operating cash flow over the twelve months to 2026-06-30, spent $40.0M on capital expenditure and had free cash flow of $117.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INSPInspire Medical Systems, Inc.Follow INSP — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
2.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-32.8-53.0-20.111.624.7130.2117.0157.1
Capital expenditure2.72.54.79.123.639.138.5-40.0
Free cash flow-35.6-55.5-24.82.51.091.178.5117.1
Share repurchases————0.00.0175.0—
Stock-based compensation6.212.826.252.082.5116.0130.3—

USD millions · SEC XBRL

Inspire Medical Systems, Inc. — questions

What is Inspire Medical Systems, Inc.'s operating cash flow?
$157.1M over the twelve months to 2026-06-30.
How much does Inspire Medical Systems, Inc. spend on capital expenditure?
$40.0M over the twelve months to 2026-06-30.
What is Inspire Medical Systems, Inc.'s free cash flow?
$117.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Inspire Medical Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.